Allergy Therapeutics PLC said its allergy treatment cleared a midstage trial that was designed to determine the optimal dose that will be studied in a further study that begins in 2019.
The company is developing a treatment known as grass modified allergen tyrosine absorbed, or Grass MATA, for people allergic to grass pollen.
The treatment is designed to boosts the body's immune system to fight allergy.
